Diminished miR-613 expression as a novel prognostic biomarker for human ovarian cancer

European Review for Medical and Pharmacological Sciences

Volumn 20, Issue 5, 2016, Pages 837-841

  Zhang, X ^a   Zhang, H ^b  

^a FIRST PEOPLE S HOSPITAL OF SHANGQIU   (China)

^b Hospital of Traditional Chinese Medicine of Sui Xian   (China)

Author keywords

Mir 613; Ovarian cancer; Overall survival; Progression free survival; Qpcr

Indexed keywords

MICRORNA; MIRN613 MICRORNA, HUMAN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; BIOSYNTHESIS; CHILD; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS, TUMOR; CHILD; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; YOUNG ADULT;

EID: 85017001694     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Knutson KL, Karyampudi L, Lamichhane P, Preston C. Targeted immune therapy of ovarian cancer. Cancer Metastasis Rev 2015; 34: 53-74.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol 2014; 9: 287-314.
4. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 2005; 353: 1768-1771.
5. Yin ZL, Wang YL, Ge SF, Guo TT, Wang L, Zheng XM, Liu J. Reduced expression of miR-503 is associated with poor prognosis in cervical cancer. Eur Rev Med Pharmacol Sci 2015; 19: 4081-4085.
6. Xia M, Duan ML, Tong JH, Xu JG. MiR-26b suppresses tumor cell proliferation, migration and invasion by directly targeting COX-2 in lung cancer. Eur Rev Med Pharmacol Sci 2015; 19: 4728-4737.
7. Sun HB, Chen X, Ji H, Wu T, Lu HW, Zhang Y, Li H, Li YM. miR494 is an independent prognostic factor and promotes cell migration and invasion in colorectal cancer by directly targeting PTEN. Int J Oncol 2014; 45: 2486-2494.
8. Fu X, Cui Y, Yang S, Xu Y, Zhang Z. MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS. Tumour Biol 2015 Dec 2. [Epub ahead of print].
9. Yang Z, Yuan Z, Fan Y, Deng X, Zheng Q. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma. Mol Med Rep 2013; 8: 1353-1358.
10. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005; 65: 3509-3512.
11. Li ZB, Li ZZ, Li L, Chu HT, Jia M. MiR-21 and miR- 183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells. Eur Rev Med Pharmacol Sci 2015; 19: 3208-3217.
12. Huang Y, Yang YB, Zhang XH, Yu XL, Wang ZB, Cheng XC. MicroRNA-21 gene and cancer. Med Oncol 2013; 30: 376.
13. Guan S, Wang C, Chen X, Liu B, Tan B, Liu F, Wang D, Han L, Wang L, Huang X, Wang J, Yao B, Shi J, Chen P, Nesa EU, Song Q, Cheng Y. MiR-613: A novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma. Tumour Biol 2015 Oct 24. [Epub ahead of print].